Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

328
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
328
Regulation of Metabolism01:19

Regulation of Metabolism

9.7K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.8K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

751
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
751
Introduction to Metabolism01:30

Introduction to Metabolism

233
Metabolism encompasses all biochemical reactions in a living organism, facilitating both the breakdown and synthesis of biomolecules. These metabolic processes are categorized into catabolic and anabolic pathways, which operate in a coordinated manner to ensure energy balance and cellular function.Catabolic Pathways and Energy ReleaseCatabolic pathways involve the breakdown of complex macromolecules such as carbohydrates, lipids, and proteins into smaller structures like monosaccharides, fatty...
233
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

169
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomics Biomarkers for Breast Cancer: An updated perspective.

Clinical breast cancer·2025
Same author

A Therapeutic Approach of Chitosan-loaded <i>p</i>-Coumaric Acid Nanoparticles to Alleviate Diabetic Nephropathy in Wistar Rats.

Current pharmaceutical biotechnology·2025
Same author

Author Correction: Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis.

Scientific reports·2025
Same author

Natural Compounds in Kidney Disease: Therapeutic Potential and Drug Development.

Biomolecules & therapeutics·2024
Same author

Effect of Prunetin on Streptozotocin-Induced Diabetic Nephropathy in Rats - a Biochemical and Molecular Approach.

Biomolecules & therapeutics·2023
Same author

<i>p</i>-Coumaric Acid Nanoparticles Ameliorate Diabetic Nephropathy via Regulating mRNA Expression of KIM-1 and GLUT-2 in Streptozotocin-Induced Diabetic Rats.

Metabolites·2022

Related Experiment Video

Updated: Aug 19, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.8K

Therapeutics in Metabolic Diseases.

Vijayakumar Natesan1

  • 1Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India. nvkbiochem@yahoo.co.in.

Advances in Experimental Medicine and Biology
|December 1, 2022
PubMed
Summary

Metabolic diseases pose significant health risks, increasing the likelihood of conditions like diabetes and stroke. Management primarily involves lifestyle changes, with pharmacotherapies and emerging gene therapies offering further treatment options.

Keywords:
Diabetes mellitusDyslipidemiaHypertensionMetabolic diseasesObesityRare diseases

More Related Videos

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

620
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

305

Related Experiment Videos

Last Updated: Aug 19, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.8K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

620
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

305

Area of Science:

  • Metabolic and genetic disorders
  • Cardiovascular and neurological health
  • Pharmacology and nanomedicine

Background:

  • Metabolic diseases significantly impact individual health and healthcare costs.
  • These conditions increase the risk of atherosclerotic coronary disease, diabetes mellitus, and complications like stroke.
  • Rare metabolic diseases also present unique clinical challenges.

Purpose of the Study:

  • To review the understanding of metabolic diseases, including their causes, symptoms, and evaluation.
  • To explore current and emerging therapeutic strategies for metabolic disorders.
  • To highlight the role of lifestyle changes, pharmacotherapies, gene therapy, and nanomedicine.

Main Methods:

  • Literature review of metabolic disease history, causes, symptoms, and evaluations.
  • Analysis of treatment modalities including lifestyle modifications, pharmacotherapies, and gene transfer.
  • Exploration of novel therapeutic approaches like hormone-based therapies and herbal extracts with nano-drug delivery.

Main Results:

  • Lifestyle changes are the cornerstone of metabolic disorder management.
  • Pharmacotherapies, including those for rare diseases, are crucial when lifestyle changes are insufficient.
  • Gene therapy offers new avenues for treating genetic metabolic conditions, potentially improving quality of life.

Conclusions:

  • Comprehensive understanding of metabolic diseases is essential for effective treatment.
  • A multi-faceted approach combining lifestyle, medication, and innovative therapies like gene transfer and nanomedicine is key.
  • Emerging nanotechnologies and herbal extracts show promise for advanced drug delivery in metabolic disease treatment.